Conversely, TUBA1B expression negatively correlated with immune killer cells, including NK/NKT cells, CD4+ T cells, and CD8+ T cells, which are essential for anti-tumor immunity, indicating that elevated TUBA1B levels may inhibit effective immune responses. The gene discussed is CD8A; the disease is neoplasm.